Company Dossier · Health / AI / SaaS
New York, NY · Est. 2019
Camber rebuilds the plumbing of healthcare payments.
The AI billing platform that turns claims chaos into software - so specialty clinics get paid faster, and more often.
The AI billing platform that turns claims chaos into software - so specialty clinics get paid faster, and more often.
Every year, US healthcare loses more than $125 billion in legitimate revenue that providers earned but never collected - lost to denied claims, coding errors, and the slow grind of insurer paperwork. Camber's argument is that this is a software problem, not a staffing one.
Camber builds revenue cycle management (RCM) software for specialty care clinics. In plain terms: when a therapist treats a child with autism or a physical therapist rehabilitates a knee, someone has to turn that visit into a clean insurance claim, submit it, chase the denial if it bounces, and reconcile the payment when it lands. Traditionally that work is done by billing firms running large call centers and charging a percentage of every dollar collected.
Camber replaces that model with an automated platform. It ingests data from electronic health records, clearinghouses, and payer portals; scrubs and validates each claim against payer-specific rules; predicts denials before submission; and reconciles payments automatically. Humans step in only for the exceptions that genuinely need judgment.
The company reports a first-pass paid rate of roughly 95% - meaning most claims are accepted the first time - in a field where 60% to 80% is common. Providers using the platform recover revenue that would otherwise slip away, and get a clearer view of when the money will actually arrive.
Founded in New York in 2019 as Juniper, the company rebranded to Camber in 2025 as it grew past its original niche in autism (ABA) therapy billing into physical therapy, ENT and allergy, and adjacent specialties.
In billing, the first-pass paid rate - the share of claims accepted on first submission - decides how much revenue a clinic keeps and how fast it arrives. Camber's pitch lives in this gap.
The difference compounds. A clinic reclaiming even a slice of that lost 30% can afford to treat more patients - which is the outcome Camber tends to point to when it describes its own success.
Camber describes its product as an integrated stack - from raw data ingestion to the financial numbers a clinic owner actually watches.
Automated generation, scrubbing, and validation against payer-specific rules to push first-pass paid rates toward 95%.
Predicts and prevents denials before submission, then auto-triages and follows up on the exceptions that remain.
Real-time collections visibility, denial-pattern analysis, payer performance tracking, and site-level reporting.
Automatic payment reconciliation with real-time flagging of discrepancies between what was billed and what was paid.
Risk scoring and workflow routing that adapts as payers change their rules and as claim patterns shift.
Data-driven guidance including clinic location analysis and visibility into payer contract negotiations.
Camber deliberately started where billing is messiest and most repetitive: recurring specialty care.
Its customers are ABA (applied behavior analysis) clinics treating children with autism and Down syndrome, physical therapy practices, and ENT and allergy providers - ranging from single-site clinics to multi-state group practices. Publicly, the company cites 500+ providers, roughly 90,000 to 100,000 patients, and more than a million claims processed each year across all 50 states.
The business model is B2B SaaS. Rather than taking a large percentage cut like a traditional billing outsourcer, Camber sells software that automates the revenue cycle. Its next frontier, announced alongside the Series B, is expansion into home health, long-term care, and substance use disorder billing - specialties with the same recurring, high-volume claims profile.
"Camber aims to fix structural problems in reimbursement that cost the industry over $125 billion a year."
Trained on $2.5B+ in real claims - one of the largest specialty-care datasets in RCM.
The clearest line between Camber and its rivals is philosophical: traditional RCM firms grow by hiring more people to make more phone calls. Camber grows by writing more software.
That distinction matters because the two models move in opposite directions. A call-center operation gets more expensive as it scales; a software platform, once built, gets cheaper per claim. Camber calls this an "infrastructure-first" approach and lists it near the top of its values.
Its second advantage is data. Because the platform has processed billions of dollars in claims across multiple specialties, it can recognize the specific patterns that trigger a given payer's denials - and correct them before a claim ever goes out. Rivals without that dataset are, in effect, guessing.
Competitors range from legacy billing outsourcers and BPO firms to healthtech RCM players like Waystar, Athenahealth, and AdvancedMD. Camber's wedge is depth in specialties those broad platforms treat as edge cases - and a willingness to own the whole claim lifecycle rather than sell a point tool.
The founders - Christophe Rimann (CEO), Celina Qi, and Nathan Lee - describe the company as operator-led, reserving human judgment for the exceptions while letting software handle the repetitive majority.
Started as a billing tool for a single ABA therapy clinic.
Raised seed capital to build a payer-specific rules engine.
Reached ABA market leadership, processing 250,000+ claims a year.
Selected for Y Combinator's Winter 2022 batch.
Closed Series A and expanded into physical therapy and ENT/allergy.
Raised $30M led by a16z (total ~$50M) and rebranded from Juniper to Camber.
Andreessen Horowitz has followed the company from angel check to Series B lead - a rare degree of conviction.
| Round | Amount | Date | Key Investors |
|---|---|---|---|
| Seed | Undisclosed | 2020 | Y Combinator, angels |
| Series A | Part of ~$50M total | 2023 | Andreessen Horowitz, Craft Ventures, ACME |
| Series B | $30M | Feb 2025 | a16z (lead), ACME, Craft, K Ventures, Y Combinator |
Note: Public reporting places total funding at approximately $50M. Round-by-round amounts prior to the Series B are not fully disclosed.
Profile compiled from public sources including camber.health, Andreessen Horowitz, BusinessWire, Axios, and Y Combinator. Figures such as first-pass paid rates and patient counts are as reported by the company or its investors and are approximate. Camber was formerly known as Juniper.